detect
cardiac
conduct
defect
week
old
foetu
absenc
structur
abnorm
predict
near
certainti
presenc
autoantibodi
ssaro
mother
regardless
health
statu
previou
studi
emphas
autoantibodi
key
mediat
tissu
injuri
aim
studi
focu
respons
determin
whether
autoantibodi
origin
progenitor
inher
selfreact
bcell
acquir
selfreact
immun
respons
trace
evolut
two
autoantibodi
isol
circul
bcell
asymptomat
mother
child
third
degre
congenit
heart
block
autoantibodi
express
immun
form
preimmun
ancestor
revert
somat
mutat
germlin
sequenc
reactiv
preimmun
immun
antibodi
la
dna
measur
autoantibodi
exhibit
low
frequenc
somat
mutat
utilis
heavi
light
chain
gene
repres
distinct
clone
base
differ
complementar
determin
region
sequenc
preand
postimmun
antibodi
show
specif
bind
measur
reactiv
autoantigen
bind
higher
immun
antibodi
compar
preimmun
counterpart
demonstr
autoreact
enhanc
affin
matur
data
indic
reactiv
intrins
properti
germlin
antibodi
repertoir
mother
pathogen
antibodi
defin
cardiac
injuri
offspr
impli
defect
central
peripher
toler
mechan
cardiac
diseas
neonat
lupu
cardiac
nl
passiv
acquir
autoimmun
syndrom
normal
develop
foetus
suffer
irrevers
damag
heart
upon
transplacent
passag
matern
igg
autoantibodi
autoab
cardiac
conduct
defect
characterist
congenit
heart
block
detect
birth
absenc
structur
abnorm
almost
univers
predict
presenc
autoab
ssaro
mother
regardless
health
statu
two
hypothes
emerg
explain
pathogenesi
cardiac
nl
emphas
autoab
central
mediat
tissu
injuri
foetal
heart
apoptosi
hypothesi
state
intracellular
ssaro
antigen
transloc
surfac
cardiomyocyt
undergo
apoptosi
physiolog
remodel
bound
matern
autoab
form
immun
complex
promot
proinflammatori
profibrot
respons
second
hypothesi
propos
autoab
crossreact
myocyt
surfac
protein
specif
ltype
calcium
channel
caus
dysregul
calcium
homeostasi
extens
investig
pathogenesi
antissaro
autoab
cardiac
nl
studi
address
autoab
deriv
elucid
origin
autoab
respons
critic
understand
autoimmun
mother
propos
target
therapi
autoantibodi
aris
two
potenti
sourc
b
cell
born
self
reactiv
assembl
ig
surfac
receptor
moder
affin
self
antigen
bone
marrow
b
cell
acquir
self
reactiv
chanc
somat
hypermut
immun
respons
b
cell
bear
antibodi
heavi
chain
variabl
segment
exampl
b
cell
born
selfreact
despit
bind
patholog
signific
blood
cell
surfac
autoantigen
b
cell
avoid
clonal
delet
bone
marrow
constitut
circul
b
cell
repertoir
healthi
individu
howev
cell
display
characterist
anergi
downregul
surfac
igm
function
unrespons
recent
b
cell
shown
particip
immun
respons
foreign
antigen
acquir
mutat
remov
bind
selfblood
cell
demonstr
clonal
redempt
mechan
acquir
selfnonself
discrimin
mutat
away
self
contrast
clonal
redempt
studi
demonstr
somat
hypermut
mean
acquir
selfreact
specif
autoantigen
includ
dsdna
sle
type
interferon
air
defici
pemphigu
gmcsf
pulmonari
alveolar
proteinosi
studi
revers
antibodi
somat
hypermut
germlin
sequenc
result
measur
interact
selfantigen
find
impli
selfreact
acquir
chanc
immun
respons
unrel
exogen
antigen
goal
studi
determin
whether
antissaro
autoab
deriv
b
cell
intrins
selfreact
acquir
autoreact
isol
autoab
asymptomat
mother
whose
offspr
affect
cardiac
nl
show
autoab
deriv
nascent
selfreact
b
cell
requir
littl
somat
mutat
data
demonstr
reactiv
inher
properti
germlin
antibodi
repertoir
mother
pathogen
autoab
defin
cardiac
injuri
offspr
peripher
blood
obtain
two
mother
enrol
research
registri
neonat
lupu
mother
posit
antiro
autoab
determin
nyu
langon
medic
centr
diagnost
immunolog
laboratori
use
system
ana
screen
mdss
biorad
ssa
ro
enzym
link
immunosorb
assay
elisa
kit
immuno
diagnost
reactiv
la
also
evalu
inhous
elisa
describ
section
mother
least
one
pregnanc
offspr
affect
cardiac
nl
donor
select
base
sever
foetal
symptom
specif
one
child
cardiac
diseas
pregnanc
result
death
foetu
studi
approv
institut
review
board
two
human
monoclon
antibodi
mab
develop
previous
describ
modif
briefli
peripher
blood
mononuclear
cell
pbmc
transform
epsteinbarr
viru
ebv
cultur
polyclon
b
cell
activ
cpg
enhanc
ebv
infect
b
cell
transform
cultur
supernat
screen
bind
activ
recombin
nativ
nativ
la
elisa
see
reactiv
cell
fuse
heteromyeloma
cell
line
result
hybridoma
cell
continu
make
function
antibodi
clone
cell
per
well
twice
cell
per
well
plate
achiev
monoclon
specif
mab
confirm
elisa
absenc
reactiv
control
antigen
hybridoma
cell
use
isol
mrna
use
microfasttrack
kit
invitrogen
ny
usa
determin
nucleotid
sequenc
describ
briefli
rapid
amplif
cdna
end
race
appli
onesid
pcr
obtain
fulllength
cdna
without
introduc
mutat
framework
region
immunoglobulin
gene
first
strand
cdna
synthes
use
gene
specif
primer
superscript
ii
rnase
h
revers
transcriptas
invitrogen
homopolymer
tail
ad
cdna
use
tdt
dctp
abridg
anchor
primer
second
gene
specif
primer
use
amplifi
immunoglobulin
gene
pcr
product
clone
topo
ta
clone
invitrogen
vector
sequenc
macrogen
rockvil
md
somat
mutat
closest
match
v
j
element
manual
annot
use
imgt
vquest
junction
analysi
tool
heavi
light
chain
cdna
sequenc
synthes
mutat
immun
form
preimmun
ancestor
somat
mutat
revert
germlin
sequenc
preimmun
postimmun
mab
express
purifi
describ
reed
fulllength
recombin
la
gener
describ
nativ
bovin
la
purchas
arotec
diagnost
elisa
done
previous
describ
modif
antigen
pb
coat
microtitr
plate
overnight
non
specif
site
block
bsa
pb
hr
room
temperatur
cell
cultur
supernat
purifi
mab
serum
dilut
bsa
pb
ad
well
room
temperatur
polyreact
evalu
elisa
describ
previous
use
doubl
strand
ds
dna
lp
antibodi
serv
posit
neg
control
polyreact
respect
determin
whether
ssaro
reactiv
inborn
acquir
endeavour
isol
antissaro
mab
mother
children
cardiac
manifest
nl
tabl
mother
posit
autoab
patient
also
low
titr
antila
autoab
patient
diagnos
system
lupu
erythematosu
sle
sjogren
syndrom
ss
patient
one
time
photosensit
otherwis
asymptomat
found
antiro
autoab
diagnosi
heart
block
foetu
screen
supernat
patient
pbmcderiv
hybridoma
reveal
two
mab
reactiv
tabl
mab
isol
donor
absenc
mab
obtain
may
due
differ
medic
use
patient
take
hydroxychlorquin
sless
symptom
sinc
hydroxychloroquin
interfer
tolllik
receptor
tlr
signal
possibl
use
cpg
oligodeoxynucleotid
activ
enhanc
ebv
infect
inhibit
donor
b
cell
result
reduc
transform
effici
factor
addit
medic
may
contribut
differ
isol
mab
previou
studi
isol
mab
patient
sle
despit
patient
untreat
seroposit
ro
larger
cohort
studi
requir
address
effect
medic
diseas
activ
factor
locat
number
autoreact
b
cell
reactiv
mab
utilis
variabl
v
join
j
heavi
light
chain
gene
segment
pair
howev
antibodi
repres
distinct
clone
base
differ
heavi
chain
complementar
determin
region
cdr
homolog
differ
divers
gene
segment
comparison
antibodi
imgt
databasederiv
germlin
sequenc
reveal
low
frequenc
somat
hypermut
tabl
overal
heavi
chain
variabl
region
mutat
respect
lower
averag
somat
mutat
rate
observ
switch
memori
b
cell
healthi
individu
previou
studi
sequenc
memori
b
cell
patient
sle
serumderiv
autoab
also
report
usag
autoab
antibodi
contain
mutat
heavi
chain
region
upstream
imgt
number
previous
report
autoab
patient
sjogren
syndrom
given
common
mutat
across
unrel
patient
like
contribut
increas
affin
given
sever
human
autoab
report
aris
somat
hypermut
next
investig
whether
somat
hypermut
requir
reactiv
antibodi
express
immun
mutat
form
preimmun
state
produc
revert
somat
hypermut
back
predict
germlin
sequenc
figur
b
b
elisa
antigen
use
evalu
reactiv
express
immun
antibodi
revert
preimmun
ancestor
preimmun
react
although
bind
preimmun
significantli
less
mutat
counterpart
mean
od
across
concentr
vs
preimmun
vs
immun
respect
p
unpair
ttest
figur
similarli
preimmun
antibodi
show
less
bind
compar
mutat
antibodi
vs
respect
p
figur
germlin
reactiv
affin
matur
highli
specif
polyreact
antigen
la
dsdna
lp
detect
figur
sinc
requir
somat
hypermut
recognis
antigen
like
autoab
deriv
anerg
b
cell
avoid
clonal
delet
bone
marrow
yet
underw
class
switch
affin
matur
toward
suggest
selfreact
b
cell
thwart
central
peripher
toler
mechan
instanc
selfreact
germlin
antibodi
maintain
peripheri
like
reason
ensur
breadth
antibodi
repertoir
exampl
b
cell
bear
bind
polynacetyllactosamin
carbohydr
erythrocyt
b
cell
contribut
immun
respons
undergo
somat
hypermut
remov
selfreact
contrast
autoab
show
low
frequenc
somat
hypermut
mutat
away
self
low
rate
somat
mutat
consist
possibl
origin
cell
independ
extrafollicular
plasmablast
respons
howev
affin
matur
toward
observ
compar
preimmun
counterpart
well
chronic
high
affin
high
titr
autoab
observ
patient
argu
shortliv
lowaffin
extrafollicular
respons
known
whether
crossreact
foreign
antigen
drive
initi
ongo
autoimmun
respons
patient
current
model
autoimmun
respons
propos
initi
inflammatori
episod
possibl
caus
viral
infect
increas
express
due
role
ubiquitin
ligas
regul
type
interferon
cytokin
product
via
ubiquitin
degrad
proinflammatori
transcript
factor
propos
inflamm
increas
express
also
promot
apoptosi
expos
intracellular
protein
autoab
product
current
studi
provid
import
insight
gener
autoimmun
show
autoab
aris
progenitor
intrigu
hypothesi
deriv
work
progenitor
matur
persist
evad
central
peripher
immun
toler
pathway
although
limit
studi
autoab
isol
one
patient
studi
requir
determin
whether
reactiv
autoab
compon
germlin
repertoir
healthi
nonautoimmun
donor
remov
acquir
toler
pathway
prevent
autoab
whether
specif
reactiv
uniqu
germlin
antibodi
repertoir
patient
clinic
overt
autoimmun
well
otherwis
asymptomat
pauci
symptomat
mother
pathogen
autoab
sole
defin
cardiac
nl
offspr
